CONTROLLED CLINICAL TRIAL
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

A preliminary prospective evaluation of all-ceramic crown-retained and inlay-retained fixed partial dentures.

PURPOSE: The purpose of this preliminary prospective study was to evaluate the clinical outcome of crown-retained and inlay-retained fixed partial dentures (FPDs) made from a new lithium-disilicate glass-ceramic (IPS e.max Press, Ivoclar Vivadent).

MATERIALS AND METHODS: Eighty-one 3-unit FPDs were placed in 68 patients. The FPDs replaced teeth in the anterior (8%) and posterior region (92%). All teeth were prepared according to a standardized protocol. The size of the proximal connector of the FPDs was 12 mm2 (anterior) or 16 mm2 (posterior), respectively. Crown-retained FPDs were cemented either with glass ionomer (n = 20) or resin composite (n = 16), while all inlay-retained FPDs (n = 45) were cemented with resin composite. Initial follow-up was performed at 6 and 12 months and annually thereafter.

RESULTS: The mean observation periods were 48 months (for crown-retained FPDs) and 37 months (for inlay-retained FPDs). None of the crown-retained FPDs failed during the observation period, while 6 inlay-retained FPDs (13%) had to be replaced. Six cases failed because of debonding (n = 3) or a combination of debonding and fracture (n = 3). During the observation period, 2 patients died and the status of another 5 patients is unknown. The 4-year survival rate according to Kaplan-Meier was 100% for crown-retained FPDs and 89% for inlay-retained FPDs. The differences between the groups were statistically significant.

CONCLUSION: Crown-retained 3-unit FPDs made from a new glass-ceramic have a significantly better outcome up to 5 years than inlay-retained 3-unit FPDs over the observation period.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app